Immunovant Ownership | Who Owns Immunovant?

Overview Forecast RevenueFinancials Chart Transcripts

Immunovant Ownership Summary

Immunovant is owned by 15.02% institutional investors, 57.26% insiders, and 27.72% retail investors. Fmr is the largest institutional shareholder, holding 9.34% of IMVT shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.36% of its assets in Immunovant shares.

IMVT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Immunovant	15.02%	57.26%	27.72%
Sector	Healthcare Stocks	35.56%	12.08%	52.36%
Industry	Biotech Stocks	35.43%	12.01%	52.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	16.95M	9.34%	$420.99M
Deep track capital, lp	11.53M	6.35%	$286.33M
Vanguard group	7.78M	4.48%	$197.75M
Blackrock	4.92M	3.56%	$129.79M
Blackrock funding, inc. /de	7.18M	3.53%	$276.68M
Baker bros. advisors lp	5.46M	3.01%	$135.57M
Tcg crossover management	4.46M	2.46%	$110.74M
State street	4.62M	2.27%	$177.89M
Morgan stanley	3.88M	2.14%	$96.30M
T. rowe price investment management	3.61M	1.99%	$89.74M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Alpine global management	2.64M	9.81%	$65.50M
Superstring capital management lp	357.61K	6.35%	$8.88M
Deep track capital, lp	11.53M	4.68%	$286.33M
Stempoint capital lp	746.49K	3.60%	$18.54M
Adar1 capital management	2.24M	3.39%	$36.14M
Tcg crossover management	4.46M	3.17%	$110.74M
Great point partners	545.63K	3.11%	$13.55M
Armistice capital	3.56M	1.57%	$88.55M
Highvista strategies	225.14K	1.54%	$5.59M
Logos global management lp	1.07M	1.33%	$26.70M

Top Buyers

Holder	Shares	% Assets	Change
Tcg crossover management	4.46M	3.17%	2.80M
Adar1 capital management	2.24M	3.39%	1.71M
Farallon capital management	1.55M	0.22%	1.53M
Vanguard group	7.78M	0.00%	952.50K
Norges bank	637.95K	0.00%	637.95K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	3.56M	1.57%	-2.18M
Point72 asset management	-	-	-2.00M
T. rowe price investment management	3.61M	0.06%	-1.45M
Paradigm biocapital advisors lp	-	-	-1.36M
Viking global investors lp	-	-	-1.11M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	637.95K	0.00%	637.95K	$15.80M
Vanguard fiduciary trust	544.54K	0.00%	544.54K	$13.53M
Balyasny asset management	197.57K	0.00%	197.57K	$3.16M
Renaissance	192.50K	0.01%	192.50K	$4.78M
Dme capital management, lp	93.52K	0.07%	93.52K	$2.32M

Sold Out

Holder	Change
Reuter james wealth management	-1.00
Dunhill financial	-1.00
Physician wealth advisors	-1.00
Capital performance advisors llp	-3.00
Nelson, van denburg & campbell wealth management group	-11.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	139	-33.17%	27,270,250	-74.89%	15	0.38%	89	-22.61%	21	-61.11%
Dec 31, 2025	165	-16.24%	62,414,346	-34.42%	35	1.16%	93	-4.12%	40	-23.08%
Sep 30, 2025	191	5.52%	94,495,463	-1.81%	55	1.74%	93	-6.06%	51	2.00%
Jun 30, 2025	178	-15.64%	96,201,301	3.59%	56	1.41%	96	-25.58%	50	19.05%
Mar 31, 2025	212	2.42%	94,119,777	17.45%	64	2.15%	130	23.81%	43	-30.65%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl S	6.94M	3.36%	-
Fidelity Growth Compy Commingled Pl O	4.45M	3.04%	196.00K
Fidelity Growth Company Fund	5.09M	2.48%	-6.29K
Vanguard Total Stock Mkt Idx Inv	2.60M	1.27%	-14.64K
Vanguard Morn Total Stk Mkt Idx Investor	2.60M	1.27%	-14.64K
Vanguard US Total Market Shares ETF	2.12M	1.25%	2.26K
State Street® SPDR® S&P® Biotech ETF	2.53M	1.23%	5.81K
iShares Russell 2000 ETF	2.16M	1.04%	-38.30K
Vanguard Small Cap Index	1.88M	0.92%	10.07K
SPDR® S&P Biotech ETF	1.30M	0.74%	2.90K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 24, 2026	Pande Atul	-	Sell	$59.70K
Jul 23, 2026	Girao Tiago	Chief Financial Officer	Sell	$263.01K
Jul 23, 2026	Stout Jay S	Chief Technology Officer	Sell	$110.54K
Jul 08, 2026	Gloria Melanie	Chief Operating Officer	Sell	$76.29K
Jul 08, 2026	Gloria Melanie	Chief Operating Officer	Sell	$4.24K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	12
2026 Q2	-	25
2026 Q1	-	7
2025 Q4	1	12
2025 Q3	-	4

IMVT Ownership FAQ

Who Owns Immunovant?

Immunovant shareholders are primarily institutional investors at 15.02%, followed by 57.26% insiders and 27.72% retail investors. The average institutional ownership in Immunovant's industry, Biotech Stocks , is 35.43%, which Immunovant falls below.

Who owns the most shares of Immunovant?

Immunovant’s largest shareholders are Fmr (16.95M shares, 9.34%), Deep track capital, lp (11.53M shares, 6.35%), and Vanguard group (7.78M shares, 4.48%). Together, they hold 20.17% of Immunovant’s total shares outstanding.

Does Blackrock own Immunovant?

Yes, BlackRock owns 3.56% of Immunovant, totaling 4.92M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 129.79M$. In the last quarter, BlackRock increased its holdings by 439.33K shares, a 9.81% change.

Who is Immunovant’s biggest shareholder by percentage of total assets invested?

Alpine global management is Immunovant’s biggest shareholder by percentage of total assets invested, with 9.81% of its assets in 2.64M Immunovant shares, valued at 65.5M$.

Who is the top mutual fund holder of Immunovant shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Immunovant shares, with 3.36% of its total shares outstanding invested in 6.94M Immunovant shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools